Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Raphael Pharmaceutical Inc. (RAPH) had Stock-Based Compensation of $0.24M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-0.26M |
|
-- |
|
-- |
|
$0.25M |
|
$-0.25M |
|
$0.00M |
|
$-0.25M |
|
$-0.25M |
|
$-0.25M |
|
$-0.25M |
|
$-0.25M |
|
$-0.25M |
|
$-0.25M |
|
$-0.25M |
|
19.63M |
|
19.63M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$0.01M |
|
$0.00M |
|
$0.00M |
|
$0.01M |
|
$1.27M |
|
-- |
|
-- |
|
$1.27M |
|
$-1.26M |
|
$-1.26M |
|
$-1.26M |
|
19.63M |
|
| Cash Flow Statement Financials | |
$-0.26M |
|
-- |
|
$0.24M |
|
$0.02M |
|
$0.00M |
|
$-0.02M |
|
|
Stock-Based Compensation |
$0.24M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.00 |
|
-- |
|
-- |
|
-- |
|
-0.03 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.26M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
19.54% |
|
19.54% |
|
-3528.57% |
|
19.54% |
|
$-0.06 |
|
$-0.01 |
|
$-0.01 |
|